Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Daniella D.G. Curi, Angela Maggio Fonseca, José Antônio M. Marcondes, José Alcione M. Almeida, Vicente R. Bagnoli, José Maria Soares$suffix/text()$suffix/text() & Edmund Chada Baracat. (2012) Metformin versus lifestyle changes in treating women with polycystic ovary syndrome. Gynecological Endocrinology 28:3, pages 182-185.
Read now
Read now
Marie-Hélène Massicotte, Fabienne Langlois & Jean-Patrice Baillargeon. (2010) Current procedures for managing polycystic ovary syndrome. Expert Review of Obstetrics & Gynecology 5:1, pages 77-91.
Read now
Read now
Articles from other publishers (16)
Mugdha Jungari, Amruta Choudhary & Naresh Kumar Gill. (2023) Comprehensive Management of Polycystic Ovary Syndrome: Effect of Pharmacotherapy, Lifestyle Modification, and Enhanced Adherence Counseling. Cureus.
Crossref
Crossref
Simona Ferjan, Andrej Janez & Mojca Jensterle. (2018) Dpp4 Inhibitor Sitagliptin As A Potential Treatment Option In Metformin-Intolerant Obese Women With Polycystic Ovary Syndrome: A Pilot Randomized Study. Endocrine Practice 24:1, pages 69-77.
Crossref
Crossref
Toshiya Matsuzaki, Altankhuu Tungalagsuvd, Takeshi Iwasa, Munkhsaikhan Munkhzaya, Kiyohito Yano, Yiliyasi Mayila, Takako Tokui, Rie Yanagihara, Sumika Matsui, Takeshi Kato, Akira Kuwahara & Minoru Irahara. (2017) Clinical outcome of various metformin treatments for women with polycystic ovary syndrome. Reproductive Medicine and Biology 16:2, pages 179-187.
Crossref
Crossref
Lori D. Homa, Laura L. Burger, Ashley J. Cuttitta, Daniel E. Michele & Suzanne M. Moenter. (2015) Voluntary Exercise Improves Estrous Cyclicity in Prenatally Androgenized Female Mice Despite Programming Decreased Voluntary Exercise: Implications for Polycystic Ovary Syndrome (PCOS). Endocrinology 156:12, pages 4618-4628.
Crossref
Crossref
Hiroaki Negishi, Kazuki Nakao, Michiko Kimura, Hiroshi Takenaka & Michiharu Horikawa. (2015) Insulin resistance in nonobese Japanese women with polycystic ovary syndrome is associated with poorer glucose tolerance, delayed insulin secretion, and enhanced insulin response. Reproductive Medicine and Biology 14:3, pages 123-129.
Crossref
Crossref
Mariagrazia Stracquadanio & Lilliana CiottaMariagrazia Stracquadanio & Lilliana Ciotta. 2015. Metabolic Aspects of PCOS. Metabolic Aspects of PCOS
89
137
.
Elizabeth Buzney, Johanna Sheu, Catherine Buzney & Rachel V. Reynolds. (2014) Polycystic ovary syndrome: A review for dermatologists. Journal of the American Academy of Dermatology 71:5, pages 859.e1-859.e15.
Crossref
Crossref
Evanthia Diamanti-Kandarakis, Shahla Nader & Dimitrios PanidisStefano PalombaAngela FalboGiovanni Battista La Sala. 2013. Novel Insights into the Pathophysiology & Treatment of PCOS. Novel Insights into the Pathophysiology & Treatment of PCOS
94
108
.
Shilpi Singh, Nishat Akhtar & Jamal Ahmad. (2012) Plasma adiponectin levels in women with polycystic ovary syndrome: Impact of Metformin treatment in a case–control study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 6:4, pages 207-211.
Crossref
Crossref
Hind A. Beydoun, May A. Beydoun, Natasha Wiggins & Laurel Stadtmauer. (2012) Relationship of obesity-related disturbances with LH/FSH ratio among post-menopausal women in the United States. Maturitas 71:1, pages 55-61.
Crossref
Crossref
Gustavo Arantes Rosa Maciel, Sylvia Asaka Yamashita Hayashida, Lia Cruz Vaz da Costa, José Antonio Miguel Marcondes, Angela Maggio da Fonseca, José Maria SoaresJr.Jr. & Edmund Chada Baracat. (2011) Influence of LH and high-density lipoprotein cholesterol (HDL-C) on metformin response in women with polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology 157:2, pages 180-184.
Crossref
Crossref
Rebecca Swingler, Alero Awala & Uma Gordon. (2009) Hirsutism in young women. The Obstetrician & Gynaecologist 11:2, pages 101-107.
Crossref
Crossref
Stefano Palomba, Angela Falbo, Fulvio Zullo & Francesco OrioJr.Jr.. (2009) Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review. Endocrine Reviews 30:1, pages 1-50.
Crossref
Crossref
Jean-Patrice Baillargeon & Nadir R. Farid. 2009. Diagnosis and Management of Polycystic Ovary Syndrome. Diagnosis and Management of Polycystic Ovary Syndrome
209
232
.
Ruchi Mathur, Carolyn J. Alexander, Jacqueline Yano, Bradley Trivax & Ricardo Azziz. (2008) Use of metformin in polycystic ovary syndrome. American Journal of Obstetrics and Gynecology 199:6, pages 596-609.
Crossref
Crossref
Susanne Tan, Susanne Hahn, Sven Benson, Tiina Dietz, Harald Lahner, Lars C Moeller, Markus Schmidt, Sigrid Elsenbruch, Rainer Kimmig, Klaus Mann & Onno E Janssen. (2007) Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance. European Journal of Endocrinology 157:5, pages 669-676.
Crossref
Crossref